24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Pyroptosis, metabolism, and tumor immune microenvironment

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In response to a wide range of stimulations, host cells activate pyroptosis, a kind of inflammatory cell death which is provoked by the cytosolic sensing of danger signals and pathogen infection. In manipulating the cleavage of gasdermins (GSDMs), researchers have found that GSDM proteins serve as the real executors and the deterministic players in fate decisions of pyroptotic cells. Whether inflammatory characteristics induced by pyroptosis could cause damage the host or improve immune activity is largely dependent on the context, timing, and response degree. Here, we systematically review current points involved in regulatory mechanisms and the multidimensional roles of pyroptosis in several metabolic diseases and the tumor microenvironment. Targeting pyroptosis may reveal potential therapeutic avenues.

          Abstract

          1. Gasdermins are executors of pyroptosis, which cause inflammatory cell death, accompanied with various inflammatory mediators.

          2. Pyroptosis plays a dual role in tumor microenvironment, including anti‐tumor and pro‐tumor effects.

          3. Pyroptosis can be used as a new target to fight against the tumor.

          Related collections

          Most cited references297

          • Record: found
          • Abstract: found
          • Article: not found

          Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

          Cancer treatment by immune checkpoint blockade (ICB) can bring long-lasting clinical benefits, but only a fraction of patients respond to treatment. To predict ICB response, we developed TIDE, a computational method to model two primary mechanisms of tumor immune evasion: the induction of T cell dysfunction in tumors with high infiltration of cytotoxic T lymphocytes (CTL) and the prevention of T cell infiltration in tumors with low CTL level. We identified signatures of T cell dysfunction from large tumor cohorts by testing how the expression of each gene in tumors interacts with the CTL infiltration level to influence patient survival. We also modeled factors that exclude T cell infiltration into tumors using expression signatures from immunosuppressive cells. Using this framework and pre-treatment RNA-Seq or NanoString tumor expression profiles, TIDE predicted the outcome of melanoma patients treated with first-line anti-PD1 or anti-CTLA4 more accurately than other biomarkers such as PD-L1 level and mutation load. TIDE also revealed new candidate ICB resistance regulators, such as SERPINB9 , demonstrating utility for immunotherapy research.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.

            Inflammatory caspases (caspase-1, -4, -5 and -11) are critical for innate defences. Caspase-1 is activated by ligands of various canonical inflammasomes, and caspase-4, -5 and -11 directly recognize bacterial lipopolysaccharide, both of which trigger pyroptosis. Despite the crucial role in immunity and endotoxic shock, the mechanism for pyroptosis induction by inflammatory caspases is unknown. Here we identify gasdermin D (Gsdmd) by genome-wide clustered regularly interspaced palindromic repeat (CRISPR)-Cas9 nuclease screens of caspase-11- and caspase-1-mediated pyroptosis in mouse bone marrow macrophages. GSDMD-deficient cells resisted the induction of pyroptosis by cytosolic lipopolysaccharide and known canonical inflammasome ligands. Interleukin-1β release was also diminished in Gsdmd(-/-) cells, despite intact processing by caspase-1. Caspase-1 and caspase-4/5/11 specifically cleaved the linker between the amino-terminal gasdermin-N and carboxy-terminal gasdermin-C domains in GSDMD, which was required and sufficient for pyroptosis. The cleavage released the intramolecular inhibition on the gasdermin-N domain that showed intrinsic pyroptosis-inducing activity. Other gasdermin family members were not cleaved by inflammatory caspases but shared the autoinhibition; gain-of-function mutations in Gsdma3 that cause alopecia and skin defects disrupted the autoinhibition, allowing its gasdermin-N domain to trigger pyroptosis. These findings offer insight into inflammasome-mediated immunity/diseases and also change our understanding of pyroptosis and programmed necrosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The NLRP3 inflammasome: molecular activation and regulation to therapeutics

              NLRP3 (NACHT, LRR and PYD domains-containing protein 3) is an intracellular sensor that detects a broad range of microbial motifs, endogenous danger signals and environmental irritants, resulting in the formation and activation of the NLRP3 inflammasome. Assembly of the NLRP3 inflammasome leads to caspase-1-dependent release of the proinflammatory cytokines, IL-1β and IL-18, as well as to gasdermin D-mediated pyroptotic cell death. Recent studies have revealed new regulators of the NLRP3 inflammasome, including new interacting or regulatory proteins, metabolic pathways and a regulatory mitochondrial hub. In this Review, we present the molecular, cell biological and biochemical basis of NLRP3 activation and regulation, and describe how this mechanistic understanding is leading to potential therapeutics that target the NLRP3 inflammasome.
                Bookmark

                Author and article information

                Contributors
                niderouke@163.com
                cxwang@sdu.edu.cn
                lutaodu@sdu.edu.cn
                Journal
                Clin Transl Med
                Clin Transl Med
                10.1002/(ISSN)2001-1326
                CTM2
                Clinical and Translational Medicine
                John Wiley and Sons Inc. (Hoboken )
                2001-1326
                03 August 2021
                August 2021
                : 11
                : 8 ( doiID: 10.1002/ctm2.v11.8 )
                : e492
                Affiliations
                [ 1 ] Department of Clinical Laboratory The Second Hospital Cheeloo College of Medicine Shandong University Jinan Shandong China
                [ 2 ] Shandong Engineering and Technology Research Center for Tumor Marker Detection Jinan Shandong China
                [ 3 ] Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory Jinan Shandong China
                Author notes
                [*] [* ] Correspondence

                Lutao Du, Chuanxin Wang, and Juan Li, Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, 247 Beiyuan Street, Jinan 250033, Shandong, China.

                Email: lutaodu@ 123456sdu.edu.cn ; cxwang@ 123456sdu.edu.cn ; niderouke@ 123456163.com

                [#]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0002-5097-9814
                Article
                CTM2492
                10.1002/ctm2.492
                8329701
                34459122
                714cb2af-209a-4d32-a9b0-84f12234f6fd
                © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 17 June 2021
                : 31 January 2021
                : 21 June 2021
                Page count
                Figures: 6, Tables: 3, Pages: 29, Words: 17141
                Funding
                Funded by: the National Natural Science Foundation of China
                Award ID: 81972007
                Award ID: 81873977
                Award ID: 81874040
                Award ID: 82002228
                Award ID: 81902882
                Funded by: the National Key Research and Development Program of China
                Award ID: 2018YFC0114700
                Funded by: the Natural Science Foundation of Shandong Province
                Award ID: ZR2019PH074
                Award ID: ZR2019BH066
                Award ID: ZR201910250056
                Funded by: Taishan Scholar Program of Shandong Province
                Funded by: the Key Research and Development Program of Shandong Province
                Award ID: 2019GHZ003
                Award ID: 2018YFJH0505
                Award ID: 2019GSF108091
                Award ID: 2019GSF108218
                Categories
                Review
                Reviews
                Custom metadata
                2.0
                August 2021
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.4 mode:remove_FC converted:03.08.2021

                Medicine
                gasdermin,metabolism,pyroptosis,tumor immunity,tumor microenvironment
                Medicine
                gasdermin, metabolism, pyroptosis, tumor immunity, tumor microenvironment

                Comments

                Comment on this article